Complement activation in the central nervous system following blood-brain barrier damage in man

Complement activation in the central nervous system following blood-brain barrier damage in man
复制标题

DOI:
10.1002/ana.410400408
复制
发表时间:
1996-10-01
影响因子:
11.2
通讯作者:
Meri, S
Meri, S
中科院分区:
医学1区
文献类型:
--
作者:
Lindsberg, PJ;Ohman, J;Meri, S

文献摘要

被引文献

相似文献

中枢神经系统(CNS)实际上与循环免疫因子如补体(C)分离,补体是体液免疫和炎症的重要介质。在循环中,C不断受到抑制,以防止对宿主细胞的攻击。由于许多疾病产生异常的血脑/脑脊液(血脑/CSF)渗透性,允许C蛋白外渗,我们研究了在蛛网膜下腔出血(SAH)或脑梗死期间,C激活是否发生在体外CSF和体内CNS中。SAH后(n = 15),CSF中第0 - 2天的终末补体复合物(TCC)浓度(210 +/- 61 ng/ml)高于血浆(63 +/- 17 ng/ml),但对照组(n = 8)或缺血性卒中患者(n = 7)的CSF中为零。SAH后TCC从CSF中消除(第7 - 10天为24 +/- 10 ng/ml)。正常人CSF与血清在体外孵育也激活了末端C途径。在10个致命的缺血性脑梗死,免疫组化技术表明,伴随着中性粒细胞浸润的C9神经元片段相关的沉积。我们的结论是,C系统成为激活鞘内SAH和局灶性脑实质缺血性中风。通过促进趋化性和血管扰动,C激活可能引发非免疫性炎症,并加重血浆外渗相关疾病的CNS损伤。
The central nervous system (CNS) is virtually isolated from circulating immunological factors such as complement (C), an important mediator of humoral immunity and inflammation. In circulation, C is constantly inhibited to prevent attack on host cells. Since a host of diseases produce an abnormal blood-brain/cerebrospinal fluid (blood-brain/CSF) permeability allowing C protein extravasation, we investigated if C activation occurs in CSF in vitro and in CNS in vivo during subarachnoid hemorrhage (SAH) or brain infarction. After SAH (n = 15), the terminal complement complex (TCC) concentration on days 0 to 2 was higher in the CSF, 210 +/- 61 ng/ml, than in the plasma, 63 +/- 17 ng/ml, but null in the CSF of controls (n = 8) or patients with an ischemic stroke (n = 7). TCC was eliminated from the CSF after SAH (24 +/- 10 ng/ml on days 7 to 10). Incubation of normal human CSF with serum in vitro also activated the terminal C pathway. In 10 fatal ischemic brain infarctions, immunohistochemical techniques demonstrated neuronal fragment-associated deposition of C9 accompanied by neutrophil infiltration. We conclude that the C system becomes activated intrathecally in SAH and focally in the brain parenchyma in ischemic stroke. By promoting chemotaxis and vascular perturbation, C activation may instigate nonimmune inflammation and aggravate CNS damage in diseases associated with plasma extravasation.